Search

Your search keyword '"Ian D. Waddell"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Ian D. Waddell" Remove constraint Author: "Ian D. Waddell"
125 results on '"Ian D. Waddell"'

Search Results

51. An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cells

52. Abstract 4352: Discovery of the first cell-active inhibitors of poly(ADP Ribose) glycohydrolase through high-throughput screening and computational approaches

53. Abstract 3715: Benzimidazolone sulphonamides - potent, selective and drug-like inhibitors of poly(ADP Ribose) Glycohydrolase (PARG)

54. Abstract 3714: Optimisation of quinazolinedione sulphonamides as novel inhibitors of poly(ADP Ribose) glycohydrolase (PARG)

57. Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade

58. The hepatic glucose-6-phosphatase system in Ehrlich-ascites-tumour-bearing mice

59. Glucose-6-phosphatase in normal adult human intestinal mucosa

60. Cloning and expression of a hepatic microsomal glucose transport protein. Comparison with liver plasma-membrane glucose-transport protein GLUT 2

61. Analysis of human hepatic microsomal glucose-6-phosphatase in clinical conditions where the T2 pyrophosphate/phosphate transport protein is absent

62. Kinetic and immunologic evidence for the absence of glucose-6-phosphatase in early human chorionic villi and term placenta

63. The ontogeny of human hepatic microsomal glucose-6-phosphatase proteins

64. Abstract C39: First-in-class inhibitors of the putatively undruggable DNA repair target Poly(ADP-ribose) glycohydrolase (PARG)

65. Abstract A176: RET inhibition: Development of novel compounds and a personalized medicine strategy in lung adenocarcinoma

66. Abstract 5429: Inhibition of SMARCA2: a novel target for SMARCA4-deficient lung adenocarcinoma

67. Abstract 3656: PARG inhibition: development of novel compounds and a biomarker strategy to determine cell line sensitivity in breast cancer

68. Abstract 778: The identification and structure-guided optimisation of potent and selective inhibitors of oncogenes in medullary thyroid carcinoma and lung adenocarcinoma

69. The cachectic mediator proteolysis inducing factor activates NF-kappaB and STAT3 in human Kupffer cells and monocytes

70. Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation

71. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators

72. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k

73. Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes

74. 284 Poly(ADP-ribose) glycohydrolase (PARG) inhibitors increase nuclear poly(ADP-ribose) after methylating DNA damage

75. Abstract 2745: Pharmacological characterisation of cell active inhibitors of Poly(ADP-ribose) glycohydrolase (PARG)

76. Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3

77. Diagnosis of a novel glycogen storage disease: Type 1aSP

78. Abstract B98: Development and evaluation of selective, reversible LSD1 inhibitors from fragment startpoints

79. Abstract 3324: The discovery and optimisation of small-molecule inhibitors of human 5’-tyrosyl DNA phosphodiesterase (Tdp2)

80. Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments

82. Abstract 1139: Novel, cellular active inhibitors of G6PD, a key mediator of ROS-induced cellular stress

83. Glucose-6-phosphatase from liver nuclear envelopes

85. Regulation of hepatic microsomal glucose transport

86. Glycogen Storage Disease Diagnosed in Adults

87. The molecular basis of the hepatic microsomal glucose-6-phosphatase system

88. Identification and characterization of a hepatic microsomal glucose transport protein. T3 of the glucose-6-phosphatase system?

89. Transverse topology of glucose-6-phosphatase in rat hepatic endoplasmic reticulum

90. Activation of hepatic microsomal glucose-6-phosphate transport by prostaglandins

91. Isolation of a cDNA coding for the glucose-6-phosphatase stabilizing protein

92. Calcium activates glucose-6-phosphatase in intact rat hepatic microsomes

93. Glucose-induced apoptosis in pancreatic beta (HIT) cells

95. Clenbuterol is not an agonist of Na+ dependent creatine transport

96. Anabolic effects of a range of β2-adrenoceptor agonists in a clonal G8.P8 cell line

97. NUCLEAR ENVELOPE GLUCOSE-6-PHOSPHATASE FROM CONTROL AND THIOACETAMIDE TREATED LIVER

99. Microsomes isolated from oviductal tissue contain low levels of the specific glucose-6-phosphatase system

100. The microsomal glucose-6-phosphatase enzyme of pancreatic islets

Catalog

Books, media, physical & digital resources